Semaglutide improves metabolic dysfunction-associated steatohepatitis: A 10-year retrospective study.

Parth ShahMegan WhiteAlex SievertAlexander ConwayAdam KneepkensGregory SayukMauricio Lisker-MelmanJill E Elwing

Published in: JGH open : an open access journal of gastroenterology and hepatology (2024)

Semaglutide treatment was associated with improvement in transaminases and MASH scores. Higher odds of positive semaglutide effects were observed with longer treatment duration and were independent of weight loss.

Keyphrases

weight loss
bariatric surgery
oxidative stress
type diabetes
combination therapy
roux en y gastric bypass